Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
21.10
-0.53 (-2.45%)
At close: Nov 2, 2026, 4:00 PM EST
21.25
+0.15 (0.71%)
After-hours: Nov 2, 2026, 7:30 PM EST
Legend Biotech Employees
Legend Biotech had 3,200 employees as of June 30, 2026. The number of employees increased by 400 or 14.29% compared to the same quarter last year. That makes Legend Biotech the 8,003rd largest employer in the world and 1,449th in the United States.
Employees
3,200
Change (1Y)
400
Growth (1Y)
14.29%
Revenue / Employee
$428,803
Profits / Employee
-$30,860
Market Cap
4.09B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 3,200 | 400 | 14.29% |
| Dec 31, 2025 | 2,965 | 356 | 13.65% |
| Dec 31, 2024 | 2,609 | 783 | 42.88% |
| Dec 31, 2023 | 1,826 | 436 | 31.37% |
| Dec 31, 2022 | 1,390 | 319 | 29.79% |
| Dec 31, 2021 | 1,071 | 189 | 21.43% |
| Dec 31, 2020 | 882 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 975 |
| Acadia Pharmaceuticals | 798 |
| AbCellera Biologics | 562 |
| Travere Therapeutics | 497 |
| Xenon Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Relay Therapeutics | 202 |
| Tango Therapeutics | 137 |
LEGN News
- 6 days ago - Legend Biotech to Host Investor Conference Call on Third Quarter 2026 Results - GlobeNewsWire
- 18 days ago - Legend Biotech announces FDA clearance of LB2501 IND application - TheFly
- 18 days ago - Legend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T Therapy - GlobeNewsWire
- 20 days ago - Legend Biotech price target lowered to $68 from $74 at Barclays - TheFly
- 24 days ago - Legend Biotech price target lowered to $33 from $35 at JPMorgan - TheFly
- 25 days ago - Legend Biotech price target lowered to $56 from $58 at RBC Capital - TheFly
- 4 weeks ago - Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma - GlobeNewsWire
- 5 weeks ago - Legend Biotech announces five-year follow-up data from Cartitude-2 Cohort A - TheFly